Basilea Pharmaceutica AG (LON:0QNA)
London
· Delayed Price · Currency is GBP · Price in CHF 45.15
+0.80 (1.80%)
At close: May 2, 2025
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 488.24 million as of May 9, 2025. Its market cap has increased by 11.85% in one year.
Market Cap
488.24M
Enterprise Value
480.05M
Revenue
183.82M
Ranking
n/a
PE Ratio
7.14
Stock Price
45.15
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 231.10M to 488.24M, an increase of 111.27%. That is a compound annual growth rate of 3.60%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.88B |
| GSK plc | 56.05B |
| Haleon | 36.35B |
| Smith & Nephew | 9.26B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.32B |